196 related articles for article (PubMed ID: 11895004)
21. Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.
Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
Gene Ther; 2001 Jul; 8(14):1051-6. PubMed ID: 11526452
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy of metastatic colon carcinoma: regression of multiple hepatic metastases by adenoviral expression of bacterial cytosine deaminase.
Block A; Freund CT; Chen SH; Nguyen KP; Finegold M; Windler E; Woo SL
Cancer Gene Ther; 2000 Mar; 7(3):438-45. PubMed ID: 10766350
[TBL] [Abstract][Full Text] [Related]
23. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells.
Blackburn RV; Galoforo SS; Corry PM; Lee YJ
Cancer Res; 1998 Apr; 58(7):1358-62. PubMed ID: 9537229
[TBL] [Abstract][Full Text] [Related]
26. Intercellular trafficking of VP22-GFP fusion proteins.
Elliott G; O'Hare P
Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
[TBL] [Abstract][Full Text] [Related]
27. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
28. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
[TBL] [Abstract][Full Text] [Related]
29. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
Porosnicu M; Mian A; Barber GN
Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
Zhang S; Yuan S
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
[TBL] [Abstract][Full Text] [Related]
32. [In vitro antitumor effect of adenovirus containing CD-TK fusion gene driven by VEGF promoter on LoVo cells].
Huang ZH; Chen JX; Su GQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):521-3. PubMed ID: 15897123
[TBL] [Abstract][Full Text] [Related]
33. Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Gene Ther; 2006 Aug; 13(16):1235-43. PubMed ID: 16617300
[TBL] [Abstract][Full Text] [Related]
34. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
35. Intercellular spread of GFP-VP22.
Aints A; Dilber MS; Smith CI
J Gene Med; 1999; 1(4):275-9. PubMed ID: 10738560
[TBL] [Abstract][Full Text] [Related]
36. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
37. [Gene therapy for ovarian cancer by adenovirus-mediated transduction of cytosine deaminase gene in vitro].
Li Q; Peng Z; Wang H; Yao Y; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):5-8. PubMed ID: 15600165
[TBL] [Abstract][Full Text] [Related]
38. Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status.
Bourbeau D; Lavoie G; Nalbantoglu J; Massie B
J Gene Med; 2004 Dec; 6(12):1320-32. PubMed ID: 15515126
[TBL] [Abstract][Full Text] [Related]
39. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
Mullen CA; Coale MM; Lowe R; Blaese RM
Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
[TBL] [Abstract][Full Text] [Related]
40. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
